If you have more than one test - add them one by one.

1 laboratory tests found

• $4273.00

  Order

  Jason Health

  LeukoVantage®, Myeloproliferative Neoplasms (MPN)

  Covered tests: LeukoVantage®, Myeloproliferative Neoplasms (MPN) (partial) (Quest)
  Extra tests (click to add to search): LeukoVantage®, Myeloproliferative Neoplasms (MPN) (partial) (Quest)
  

  Covered components: Mutation 2 C, Gene 2 Trial ID 2

  Extra components (click to add to search): Overall Result, Overall Summary, Gene 1, Mutation 1 P, Mutation 1 C, Mutation Frequency 1, Clinical Significance 1, Available Therapies 1, Resistance to Therapies 1, and 394 more

  Clinical Trials 1 , Mutation Effect Variant 1 , Clin Relevance Variant 1 , Prognostic Sig Variant 1 , Diagnostic Sig Variant 1 , Related Therapies 1 , Unrelated Therapies 1 , Resistance 1 , Eff on Drug Sensit 1 , Eff on Drug Resist 1 , Gene 1 Trial ID 1 , Gene 1 Title 1 , Gene 1 Targets 1 , Gene 1 Trial ID 2 , Gene 1 Title 2 , Gene 1 Targets 2 , Gene 1 Trial ID 3 , Gene 1 Title 3 , Gene 1 Targets 3 , Gene 1 Trial ID 4 , Gene 1 Title 4 , Gene 1 Targets 4 , Gene 1 Trial ID 5 , Gene 1 Title 5 , Gene 1 Targets 5 , Gene 1 Trial ID 6 , Gene 1 Title 6 , Gene 1 Targets 6 , Gene 1 Trial ID 7 , Gene 1 Title 7 , Gene 1 Targets 7 , Gene 1 Trial ID 8 , Gene 1 Title 8 , Gene 1 Targets 8 , Gene 1 Trial ID 9 , Gene 1 Title 9 , Gene 1 Targets 9 , Gene 1 Trial ID 10 , Gene 1 Title 10 , Gene 1 Targets 10 , Footnote for Variant , Gene 2 , Mutation 2 P , Mutation Frequency 2 , Clinical Significance 2 , Available Therapies 2 , Resistance to Therapies 2 , Clinical Trials 2 , Mutation Effect Variant 2 , Clin Relevance Variant 2 , Prognostic Sig Variant 2 , Diagnostic Sig Variant 2 , Related Therapies 2 , Unrelated Therapies 2 , Resistance 2 , Effect on Drug Sensit 2 , Effect on Drug Resist 2 , Gene 2 Trial ID 1 , Gene 2 Title 1 , Gene 2 Targets 1 , Gene 2 Title 2 , Gene 2 Targets 2 , Gene 2 Trial ID 3 , Gene 2 Title 3 , Gene 2 Targets 3 , Gene 2 Trial ID 4 , Gene 2 Title 4 , Gene 2 Targets 4 , Gene 2 Trial ID 5 , Gene 2 Title 5 , Gene 2 Targets 5 , Gene 2 Trial ID 6 , Gene 2 Title 6 , Gene 2 Targets 6 , Gene 2 Trial ID 7 , Gene 2 Title 7 , Gene 2 Targets 7 , Gene 2 Trial ID 8 , Gene 2 Title 8 , Gene 2 Targets 8 , Gene 2 Trial ID 9 , Gene 2 Title 9 , Gene 2 Targets 9 , Gene 2 Trial ID 10 , Gene 2 Title 10 , Gene 2 Targets 10 , Gene 3 , Mutation 3 P , Mutation 3 C , Mutation Frequency 3 , Clinical Significance 3 , Available Therapies 3 , Resistance to Therpies 3 , Clinical Trials 3 , Mutation Effect Variant 3 , Clin Relevance Variant 3 , Prognostic Sig Variant 3 , Diagnostic Sig Variant 3 , Related Therapies 3 , Unrelated Therapies 3 , Resistance 3 , Effect on Drug Sensit 3 , Effect on Drug Resist 3 , Gene 3 Trial ID 1 , Gene 3 Title 1 , Gene 3 Targets 1 , Gene 3 Trial ID 2 , Gene 3 Title 2 , Gene 3 Targets 2 , Gene 3 Trial ID 3 , Gene 3 Title 3 , Gene 3 Targets 3 , Gene 3 Trial ID 4 , Gene 3 Title 4 , Gene 3 Targets 4 , Gene 3 Trial ID 5 , Gene 3 Title 5 , Gene 3 Targets 5 , Gene 3 Trial ID 6 , Gene 3 Title 6 , Gene 3 Targets 6 , Gene 3 Trial ID 7 , Gene 3 Title 7 , Gene 3 Targets 7 , Gene 3 Trial ID 8 , Gene 3 Title 8 , Gene 3 Targets 8 , Gene 3 Trial ID 9 , Gene 3 Title 9 , Gene 3 Targets 9 , Gene 3 Trial ID 10 , Gene 3 Title 10 , Gene 3 Targets 10 , Gene 4 , Mutation 4 P , Mutation 4 C , Mutation Frequency 4 , Clinical Significance 4 , Available Therapies 4 , Resistance to Therapies 4 , Clinical Trials 4 , Mutation Effect Variant 4 , Clin Relevance Variant 4 , Prognostic Sig Variant 4 , Diagnostic Sig Variant 4 , Related Therapies 4 , Unrelated Therapies 4 , Resistance 4 , Effect on Drug Sensit 4 , Effect on Drug Resist 4 , Gene 4 Trial ID 1 , Gene 4 Title 1 , Gene 4 Targets 1 , Gene 4 Trial ID 2 , Gene 4 Title 2 , Gene 4 Targets 2 , Gene 4 Trial ID 3 , Gene 4 Title 3 , Gene 4 Targets 3 , Gene 4 Trial ID 4 , Gene 4 Title 4 , Gene 4 Targets 4 , Gene 4 Trial ID 5 , Gene 4 Title 5 , Gene 4 Targets 5 , Gene 4 Trial ID 6 , Gene 4 Title 6 , Gene 4 Targets 6 , Gene 4 Trial ID 7 , Gene 4 Title 7 , Gene 4 Targets 7 , Gene 4 Trial ID 8 , Gene 4 Title 8 , Gene 4 Targets 8 , Gene 4 Trial ID 9 , Gene 4 Title 9 , Gene 4 Targets 9 , Gene 4 Trial ID 10 , Gene 4 Title 10 , Gene 4 Targets 10 , Gene 5 , Mutation 5 P , Mutation 5 C , Mutation Frequency 5 , Clinical Significance 5 , Available Therapies 5 , Resistance to Therapies 5 , Clinical Trials 5 , Mutation Effect Variant 5 , Clin Relevance Variant 5 , Prognostic Sig Variant 5 , Diagnostic Sig Variant 5 , Related Therapies 5 , Unrelated Therapies 5 , Resistance 5 , Effect on Drug Sensit 5 , Effect on Drug Resist 5 , Gene 5 Trial ID 1 , Gene 5 Title 1 , Gene 5 Targets 1 , Gene 5 Trial ID 2 , Gene 5 Title 2 , Gene 5 Targets 2 , Gene 5 Trial ID 3 , Gene 5 Title 3 , Gene 5 Targets 3 , Gene 5 Trial ID 4 , Gene 5 Title 4 , Gene 5 Targets 4 , Gene 5 Trial ID 5 , Gene 5 Title 5 , Gene 5 Targets 5 , Gene 5 Trial ID 6 , Gene 5 Title 6 , Gene 5 Targets 6 , Gene 5 Trial ID 7 , Gene 5 Title 7 , Gene 5 Targets 7 , Gene 5 Trial ID 8 , Gene 5 Title 8 , Gene 5 Targets 8 , Gene 5 Trial ID 9 , Gene 5 Title 9 , Gene 5 Targets 9 , Gene 5 Trial ID 10 , Gene 5 Title 10 , Gene 5 Targets 10 , Gene 6 , Mutation 6 P , Mutation 6 C , Mutation Frequency 6 , Clinical Significance 6 , Available Therapies 6 , Resistance to Therapies 6 , Clinical Trials 6 , Mutation Effect Variant 6 , Clin Relevance Variant 6 , Prognostic Sig Variant 6 , Diagnostic Sig Variant 6 , Related Therapies 6 , Unrelated Therapies 6 , Resistance 6 , Effect on Drug Sensit 6 , Effect on Drug Resist 6 , Gene 6 Trial ID 1 , Gene 6 Title 1 , Gene 6 Targets 1 , Gene 6 Trial ID 2 , Gene 6 Title 2 , Gene 6 Targets 2 , Gene 6 Trial ID 3 , Gene 6 Title 3 , Gene 6 Targets 3 , Gene 6 Trial ID 4 , Gene 6 Title 4 , Gene 6 Targets 4 , Gene 6 Trial ID 5 , Gene 6 Title 5 , Gene 6 Targets 5 , Gene 6 Trial ID 6 , Gene 6 Title 6 , Gene 6 Targets 6 , Gene 6 Trial ID 7 , Gene 6 Title 7 , Gene 6 Targets 7 , Gene 6 Trial ID 8 , Gene 6 Title 8 , Gene 6 Targets 8 , Gene 6 Trial ID 9 , Gene 6 Title 9 , Gene 6 Targets 9 , Gene 6 Trial ID 10 , Gene 6 Title 10 , Gene 6 Targets 10 , Gene 7 , Mutation 7 P , Mutation 7 C , Mutation Frequency 7 , Clinical Significance 7 , Available Therapies 7 , Resistance to Therapies 7 , Clinical Trials 7 , Mutation Effect Variant 7 , Clin Relevance Variant 7 , Prognostic Sig Variant 7 , Diagnostic Sig Variant 7 , Related Therapies 7 , Unrelated Therapies 7 , Resistance 7 , Effect on Drug Sensit 7 , Effect on Drug Resist 7 , Gene 7 Trial ID 1 , Gene 7 Title 1 , Gene 7 Targets 1 , Gene 7 Trial ID 2 , Gene 7 Title 2 , Gene 7 Targets 2 , Gene 7 Trial ID 3 , Gene 7 Title 3 , Gene 7 Targets 3 , Gene 7 Trial ID 4 , Gene 7 Title 4 , Gene 7 Targets 4 , Gene 7 Trial ID 5 , Gene 7 Title 5 , Gene 7 Targets 5 , Gene 7 Trial ID 6 , Gene 7 Title 6 , Gene 7 Targets 6 , Gene 7 Trial ID 7 , Gene 7 Title 7 , Gene 7 Targets 7 , Gene 7 Trial ID 8 , Gene 7 Title 8 , Gene 7 Targets 8 , Gene 7 Trial ID 9 , Gene 7 Title 9 , Gene 7 Targets 9 , Gene 7 Trial ID 10 , Gene 7 Title 10 , Gene 7 Targets 10 , Gene 8 , Mutation 8 P , Mutation 8 C , Mutation Frequency 8 , Clinical Significance 8 , Available Therapies 8 , Resistance to Therapies 8 , Clinical Trials 8 , Mutation Effect Variant 8 , Clin Relevance Variant 8 , Prognostic Sig Variant 8 , Diagnostic Sig Variant 8 , Related Therapies 8 , Unrelated Therapies 8 , Resistance 8 , Effect on Drug Sensit 8 , Effect on Drug Resist 8 , Gene 8 Trial ID 1 , Gene 8 Title 1 , Gene 8 Targets 1 , Gene 8 Trial ID 2 , Gene 8 Title 2 , Gene 8 Targets 2 , Gene 8 Trial ID 3 , Gene 8 Title 3 , Gene 8 Targets 3 , Gene 8 Trial ID 4 , Gene 8 Title 4 , Gene 8 Targets 4 , Gene 8 Trial ID 5 , Gene 8 Title 5 , Gene 8 Targets 5 , Gene 8 Trial ID 6 , Gene 8 Title 6 , Gene 8 Targets 6 , Gene 8 Trial ID 7 , Gene 8 Title 7 , Gene 8 Targets 7 , Gene 8 Trial ID 8 , Gene 8 Title 8 , Gene 8 Targets 8 , Gene 8 Trial ID 9 , Gene 8 Title 9 , Gene 8 Targets 9 , Gene 8 Trial ID 10 , Gene 8 Title 10 , Gene 8 Targets 10 , Variants of Unknown Sig , Biomarker w/No Alteration , Region w/Poor Seq Quality , Biomarker1 1 , Biomarker2 1 , Resistant Therapies 1 , Synergistic Therapies 1 , Diagnostic Evidence 1 , Prognostic Evidence 1 , Interaction Summary 1 , Biomarker1 2 , Biomarker2 2 , Resistant Therapies 2 , Synergistic Therapies 2 , Diagnostic Evidence 2 , Prognostic Evidence 2 , Interaction Summary 2 , Biomarker1 3 , Biomarker2 3 , Resistant Therapies 3 , Synergistic Therapies 3 , Diagnostic Evidence 3 , Prognostic Evidence 3 , Interaction Summary 3 , Footnote , Level of Evidence Descrip , Additional Information

  Blacklisted States: NY, NJ, RI

  $4255.00

  Jason Health

  Requisition Charge (per order charge)

  $18.00

  $4273.00

  Back

  Order from Jason Health

  • LeukoVantage®, Myeloproliferative Neoplasms (MPN) $4255.00

  Go to Checkout and complete the checkout process there. Your total price should be $4273.00 ($4255.00 panels price + $18.00 requisition charge)